| Itália | Turki | Austria | |
| Tomoterapi | - | dari $7,150 | dari $30,000 |
| Terapi sinar proton | - | dari $70,000 | dari $80,000 |
| Terapi hormon | - | dari $412 | dari $7,000 |
| Terapi deprivasi androgen | - | dari $1,500 | dari $4,500 |
Bookimed tidak menambah biaya tambahan dalam harga perawatan Kanker prostat. Tarif berasal dari daftar harga resmi klinik. Anda membayar langsung di klinik saat tiba di negara tujuan untuk perawatan Anda.
Bookimed berkomitmen pada keselamatan Anda. Kami hanya bekerja dengan institusi medis yang menjaga standar internasional tinggi dalam perawatan Kanker prostat dan memiliki izin yang dibutuhkan untuk melayani pasien internasional di seluruh dunia.
Bookimed menawarkan bantuan ahli gratis. Koordinator medis pribadi mendukung Anda sebelum, selama, dan setelah perawatan, menyelesaikan semua masalah Anda. Anda tidak pernah sendirian dalam perjalanan perawatan Kanker prostat Anda.
Prof. Montorsi telah melakukan lebih dari 8.000 operasi urologi, spesialisasi dalam teknik invasif minimal dan robotik untuk kanker prostat di San Raffaele.
Kepala Radioterapi di Rumah Sakit San Raffaele – Prof. Di Muzio spesialis dalam metode hipofraksinasi presisi tinggi untuk kanker prostat, dengan pengalaman lebih dari 25 tahun.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.